EBG MedAustron GmbH
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky Tumors (NCT06390657) | EBG MedAustron GmbH | 2024-06-01 |
| Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) (NCT05191940) | EBG MedAustron GmbH | 2022-05-16 |
| Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors (NCT04875871) | EBG MedAustron GmbH | 2021-11-11 |
| Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer (NCT04894643) | EBG MedAustron GmbH | 2020-09-14 |
| Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer (NCT03740191) | EBG MedAustron GmbH | 2018-07-03 |
Track EBG MedAustron GmbH automatically
Every clearance here is in the API, with alerts when new ones post.